Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 6;4(11):e302.
doi: 10.1371/journal.pmed.0040302.

Building clinical trials capacity for tuberculosis drugs in high-burden countries

Neil Schluger  1 , Unni Karunakara, Christian Lienhardt, Thomas Nyirenda, Richard Chaisson
Affiliations

Building clinical trials capacity for tuberculosis drugs in high-burden countries

Neil Schluger et al. PLoS Med. .

Abstract

The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: NS has received research grants from the United States National Institutes of Health and Centers for Disease Control and Prevention. CL has received funds from the European Commission and United States Agency for International Development. TN is Networking Manager of the European and Developing Countries Clinical Trials Partnership. RC has received research grants from the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Bill & Melinda Gates Foundation; research material donations and consulting fees from Bayer; and memberships on the World Health Organization's tuberculosis advisory board and American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Panel on TB Treatment.

Figures

Figure 1
Figure 1. A Patient with MDR-TB Holds the Dose of Drugs He Must Take Every Day
This patient checked into the hospital in November 2006 and in January 2007 he tested negative; if his progress continues, he could be sent home to finish his treatment. (Photo: Jean-Marc Giboux)
See this image and copyright information in PMC

References

    1. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3:S231–S279. - PubMed
    1. Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med. 2006;174:331–338. - PubMed
    1. Lienhardt C, Rustomjee R, Allen J, Mthiyane T, Levin J, et al. Comparison of 2-months sterilizing activities of several quinolone-containing regimens for the treatement of TB [poster LBII-13] 2005. Interscience Conference on Antimicrobial Agents and Chemotherapy; Washington, D. C. United States of America; 16–19 December 2005.
    1. Nuermberger EL, Yoshimatsu T, Tyagi S, Williams K, Rosenthal I, et al. Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. Am J Respir Crit Care Med. 2004;170:1131–1134. - PubMed
    1. Feuer C. Tuberculosis research and development: A critical analysis. Treatment Action Group. 2006. Available: http://www.aidsinfonyc.org/tag/tbhiv/tbrandd.pdf. Accessed 7 October 2007.

MeSH terms

Substances